Radiation Increases Bioavailability of Lisinopril, a Mitigator of Radiation-Induced Toxicities

• Главные авторы: Meetha Medhora (Автор), Preeya Phadnis (Автор), Jayashree Narayanan (Автор), Tracy Gasperetti (Автор), Jacek Zielonka (Автор), John E. Moulder (Автор), Brian L. Fish (Автор), Aniko Szabo (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

There are no FDA-approved drugs to mitigate the delayed effects of radiation exposure that may occur after a radiological attack or nuclear accident. To date, angiotensin-converting enzyme inhibitors are one of the most successful candidates for mitigation of hematopoietic, lung, kidney, and brain i...